Teva Pharmaceutical Industries

Bookmark

Add to MyYahoo RSS

Teva Pharmaceutical Industries News

News on Teva Pharmaceutical Industries (Ticker: TEVA) continually updated from thousands of sources around the net.

54 min ago | KRMG-AM Tulsa

Court declines to block drug ruling in patent case

Supreme Court Chief Justice John Roberts on Friday declined to temporarily block a lower court ruling that opens the world's best-selling multiple sclerosis drug to competition from generic rivals next month.

Comment?

Related Topix: US News, John G. Roberts, Biotech, Federal Circuit Court of Appeals

54 min ago | The Washington Post

Teva Rejected by U.S. Justice on Generic Copaxone Delay

A U.S. Supreme Court justice rejected Teva Pharmaceutical Industries Ltd.'s bid to block generic versions of its Copaxone multiple-sclerosis drug while the court hears the company's appeal in a patent clash.

Comment?

Related Topix: Biotech, US News, Teva Pharmaceutical Industries, Medicine, Cephalon, Pharmaceuticals, US Supreme Court, Healthcare Industry, Business News

Thu Apr 17, 2014

Reuters

UPDATE 1-Teva willing to post bond to suspend decision on Copaxone

Teva Pharmaceutical Industries Ltd on Thursday told the U.S. Supreme Court that it is willing to post up to a $500 million bond in return for a decision suspending a lower court ruling that would allow generic competitors to go on the market as soon as next month.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, US News, US Supreme Court, Federal Circuit Court of Appeals

Value Line

Drug Roundup - " April 17, 2014

There have been several noteworthy developments in the drug space recently, which will likely have a material impact on the companies in this sector and the markets they serve.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Merck , Merck & Co., Eli Lilly, Bristol Myers Squibb

Reuters

Teva, Pfizer settle patent lawsuit over painkiller Celebrex

Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Celebrex, Celecoxib (generic), Teva Pharmaceutical Industries, Pharmaceuticals, Health, Pain

Wed Apr 16, 2014

AmericanBankingNews.com

Sterne Agee Initiates Coverage on Teva Pharmaceutical Industries Ltd

The firm set a "neutral" rating on the stock. TEVA has been the subject of a number of other recent research reports.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Research and Markets: Global Testicular Cancer Drugs Market 2014-2018 With Bristol-Myers Squibb, Hospira, Teva Pharmaceutical Industries & ZIOPHARM Oncology Dominating )--Research and Markets has announced the addition of the "Global Testicular Cancer Drugs Market 2014-201... )--Research and Markets has announced the addition of the "Global ... (more)

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Cephalon, Pharmaceuticals, Healthcare Industry, SAS, Functional, Inc, Cameras

Tue Apr 15, 2014

Freshnews

Teva Announces Launch of Generic LunestaA Tablets in the United States

Teva Pharmaceutical Industries Ltd. announces the launch of the generic equivalent to Lunesta , 1, 2 and 3 mg, in the United States.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Marketing, Women's Health

Mon Apr 14, 2014

The Motley Fool

Is Teva Pharmaceutical Industries Ltd. Destined for Greatness?

Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Financial Markets, Health, Asthma

Fri Apr 11, 2014

PR-inside.com

Global testicular cancer drugs market dominated by Bristol-Myers...

One of the key factors contributing to this market growth is the increasing incidence of testicular cancer.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Teva Pharmaceutical Industries, Pharmaceuticals

Wed Apr 09, 2014

BayStreet.ca

Five Star Equities Issues New Research Reports on ECOL, MNKD, TEVA...

US Ecology Inc. shares spiked 7.69 percent to close at $38.49 a share Tuesday. The stock traded between $37.10 and $39.67 on volume 527,626 shares traded.

Comment?

Related Topix: Biotech, Environmental, American Ecology, Waste Management

Tue Apr 08, 2014

Rediff.com

Meet the man behind the Sun Pharma-Ranbaxy deal

Makov's contribution was not limited to Sunday's meeting. He played a key role in getting Daiichi to the negotiating table and ensuring the Japanese giant remained there till the deal was signed.

Comment?

Related Topix: Biotech, Food and Drug Administration

Bloomberg

Teva's Generic Copaxone Rivals Asked to Respond on Delay

A U.S. Supreme Court justice asked generic-drug makers to respond to Teva Pharmaceutical Industries Ltd. 's bid for perhaps a yearlong delay on competition to its top-selling Copaxone multiple-sclerosis drug.

Comment?

Related Topix: Biotech, US News, US Supreme Court, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Noven Pharmaceuticals, Mylan Laboratories

Pharmaceutical Processing

Teva Launches Generic Fish Oil Drug

Teva Pharmaceutical Industries said Tuesday it is now selling a generic version of the heart medication Lovaza, which is used to treat high triglyceride levels.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Supplement, Fish Oil, Healthcare Industry, Cephalon, Life, Food, Dieting

PhysOrg Weblog

Successful outcome with novel aPKC protein inhibitor cancer drug development candidate

Cancer Research Technology , the commercial arm of Cancer Research UK announces a successful outcome to their existing collaboration with Teva through the identification of a novel atypical Protein Kinase C inhibitor pre-clinical candidate, licensed by Teva.

Comment?

Related Topix: Medicine, Cancer, Health, Biotech, Prostate Cancer

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

First quarter sales reach 271,321 vehicles, up 45%. )--Research and Markets has announced the addition of the "Engerix-B - F... )--Archie Comics, the acclaimed and bestselling comic book publisher that is home to some of the best-known pop culture creations in the world, including Archie, Jughead, Be... )--FUND A db x-trackers DB HEDGE FUND INDEX ... (more)

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Marketing

Mon Apr 07, 2014

Reuters

UPDATE 1-Teva asks U.S. Supreme court to stay ruling in Copaxone case

Teva Pharmaceutical Industries Ltd asked the U.S. Supreme Court on Monday to stop a lower court ruling from going into effect while the justices consider an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone.

Comment?

Related Topix: Biotech, US News, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, US Supreme Court, Multiple Sclerosis, Health, Federal Circuit Court of Appeals

Wall Street Journal

Teva Asks to Delay Possible Release of Generic Copaxone

Teva Pharmaceutical Industries Ltd. is asking the Supreme Court to delay the possible market entry of generic versions of its blockbuster multiple-sclerosis drug Copaxone.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Sun Apr 06, 2014

The Washington Post

Soros Puts Teva Over Microsoft in Winning Bet: Israel Overnight

Teva Pharmaceutical Industries Ltd.'s surge to a three-year high is creating a windfall for billionaire George Soros after he lifted the Israeli drugmaker above Microsoft Corp. to become the biggest holding in his fund.

Comment?

Related Topix: Biotech, Microsoft, Startups, Teva Pharmaceutical Industries, Medicine, Cephalon, Pharmaceuticals, Healthcare Industry, US News, US Supreme Court, Multiple Sclerosis, Health

Fri Apr 04, 2014

Wall St. Cheat Sheet

Supreme Court Studies Generic Drug Question: How Will Patients Fare?

Perhaps not as attention-grabbing as the health care industry's struggle to adapt to the changes brought by the Affordable Care Act , its efforts to deal with what is known as the patent cliff is nevertheless a hugely important narrative for pharmaceutical companies.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Cephalon, Pharmaceuticals, Healthcare Industry, Pfizer, Lipitor, Atorvastatin (generic), Celebrex, Celecoxib (generic)

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••